跳至主要内容
临床试验/NCT06750497
NCT06750497招募中不适用

The Impact of Short-term Forearm Immobilization on Forearm Muscle Glucose and Amino Acid Metabolism of Volunteers With or Without Type 2 Diabetes

Wageningen University2 个研究点 分布在 1 个国家目标入组 26 人开始时间: 2024年11月21日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
26
试验地点
2
主要终点
Change in forearm muscle glucose uptake

研究概览

简要总结

The aim of the present study is to assess the impact of short-term forearm immobilization on forearm muscle glucose uptake and amino acid net balance and kinetics in individuals with T2D compared with a control group with normoglycaemia.

详细描述

Participants with and without T2D will undergo 2 days of forearm immobilization as a model of local physical inactivity. Before, throughout, and after immobilization arteriovenous forearm balance measurements will be combined with a stable isotope tracer infusion to measure muscle glucose uptake and amino acid balance, uptake, and efflux.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Males and females with or without diagnosed type 2 diabetes
  • Use lifestyle changes, metformin, gliclazide, or a combination thereof as oral glucose-lowering treatments for T2D
  • Aged 18-80 years at the time of signing informed consent
  • 18.5 ≥ BMI ≤ 35 kg·m2

排除标准

  • Type 1 or a genetic form of diabetes
  • Any diagnosed cardiovascular (heart) disease or high blood pressure (≥160 mmHg systolic and/or ≥100 mmHg diastolic)
  • Chronic use of any prescribed or over-the-counter pharmaceuticals (excluding oral contraceptives and contraceptive devices) that interact with muscle substrate metabolism (e.g. selective serotonin reuptake inhibitors)
  • Consumption of a low-carbohydrate diet
  • Smoking or chewing tobacco
  • Known anaemia
  • Regular use of dietary protein and/or amino acid supplements (>3 times per week)
  • Currently involved in a structured progressive resistance training program (>3 times per week)
  • A personal or family history of thrombosis (clots)
  • Any previous motor disorders or inborn errors in muscle and/or lipid metabolism
  • History of kidney disease
  • History of liver disease
  • Pregnant or breastfeeding
  • History of any drug or alcohol abuse in the past two years
  • Claustrophobia
  • Unable to give consent

研究组 & 干预措施

Participants with Type 2 Diabetes

Experimental

Two days of standardized meal consumption

干预措施: Forearm immobilization (Behavioral)

Participants without Type 2 Diabetes

Experimental

Two days of standardized meal consumption

干预措施: Forearm immobilization (Behavioral)

结局指标

主要结局

Change in forearm muscle glucose uptake

时间窗: From 0 to 48 hours

The change in postprandial muscle insulin sensitivity, measured as forearm glucose uptake, from pre-immobilization to post-immobilization

次要结局

  • Temporal change in forearm glucose uptake(Prior to and for 3.5 hours following every meal consumption during the 48 hours forearm immobilization period)
  • Change in forearm muscle amino acid kinetics(Baseline and at regular intervals for 3.5 hours following the first and last meal consumption during the test period (0 to 48 hours))
  • Change in whole-body substrate oxidation(Measurements will be performed at baseline, and at postprandial intervals (at 1 hour, 2 hours, 3 hours) during a 0 to 48-hour test period.)
  • Change in forearm muscle amino acid kinetics(Baseline and at regular intervals for 3.5 hours following the first and last meal consumption during the test period (0 to 48 hours))
  • Change in whole-body substrate oxidation(Measurements will be performed at baseline, and at postprandial intervals (at 1 hour, 2 hours, 3 hours) during a 0 to 48-hour test period.)
  • Temporal change in forearm glucose uptake(Prior to and for 3.5 hours following every meal consumption during the 48 hours forearm immobilization period)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Marlou Dirks

Assistant Professor

Wageningen University

研究点 (2)

Loading locations...

相似试验

Forearm Immobilization in T2D | 临床试验